Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors

Abstract Data on intratumoral heterogeneity of small intestine neuroendocrine tumors (SI-NETs) and related liver metastasis are limited. The aim of this study was to characterize genetic heterogeneity of 5 patients with SI-NETs. Therefore, formalin-fixed, paraffin-embedded tissue samples of primary...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dirk Walter, Patrick N. Harter, Florian Battke, Ria Winkelmann, Markus Schneider, Katharina Holzer, Christine Koch, Jörg Bojunga, Stefan Zeuzem, Martin Leo Hansmann, Jan Peveling-Oberhag, Oliver Waidmann
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b786fcb5b9e245fe84cd2828f5a059bc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b786fcb5b9e245fe84cd2828f5a059bc
record_format dspace
spelling oai:doaj.org-article:b786fcb5b9e245fe84cd2828f5a059bc2021-12-02T15:08:42ZGenetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors10.1038/s41598-018-22115-02045-2322https://doaj.org/article/b786fcb5b9e245fe84cd2828f5a059bc2018-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-22115-0https://doaj.org/toc/2045-2322Abstract Data on intratumoral heterogeneity of small intestine neuroendocrine tumors (SI-NETs) and related liver metastasis are limited. The aim of this study was to characterize genetic heterogeneity of 5 patients with SI-NETs. Therefore, formalin-fixed, paraffin-embedded tissue samples of primary and metastatic lesions as well as benign liver of five patients with synchronously metastasized, well differentiated SI-NETs were analyzed with whole exome sequencing. For one patient, chip based 850k whole DNA methylome analysis was performed of primary and metastatic tumor tissue as well as control tissue. Thereby, 156 single nucleotide variants (SNVs) in 150 genes were identified and amount of mutations per sample ranged from 9–34 (mean 22). The degree of common (0–94%) and private mutations per sample was strongly varying (6–100%). In all patients, copy number variations (CNV) were found and the degree of intratumoral heterogeneity of CNVs corresponded to SNV analysis. DNA methylation analysis of a patient without common SNVs revealed a large overlap of common methylated CpG sites. In conclusion, SI-NET primary and metastatic lesions show a highly varying degree of intratumoral heterogeneity. Driver events might not be detectable with exome analysis only, and further comprehensive studies including whole genome and epigenetic analyses are warranted.Dirk WalterPatrick N. HarterFlorian BattkeRia WinkelmannMarkus SchneiderKatharina HolzerChristine KochJörg BojungaStefan ZeuzemMartin Leo HansmannJan Peveling-OberhagOliver WaidmannNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Dirk Walter
Patrick N. Harter
Florian Battke
Ria Winkelmann
Markus Schneider
Katharina Holzer
Christine Koch
Jörg Bojunga
Stefan Zeuzem
Martin Leo Hansmann
Jan Peveling-Oberhag
Oliver Waidmann
Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
description Abstract Data on intratumoral heterogeneity of small intestine neuroendocrine tumors (SI-NETs) and related liver metastasis are limited. The aim of this study was to characterize genetic heterogeneity of 5 patients with SI-NETs. Therefore, formalin-fixed, paraffin-embedded tissue samples of primary and metastatic lesions as well as benign liver of five patients with synchronously metastasized, well differentiated SI-NETs were analyzed with whole exome sequencing. For one patient, chip based 850k whole DNA methylome analysis was performed of primary and metastatic tumor tissue as well as control tissue. Thereby, 156 single nucleotide variants (SNVs) in 150 genes were identified and amount of mutations per sample ranged from 9–34 (mean 22). The degree of common (0–94%) and private mutations per sample was strongly varying (6–100%). In all patients, copy number variations (CNV) were found and the degree of intratumoral heterogeneity of CNVs corresponded to SNV analysis. DNA methylation analysis of a patient without common SNVs revealed a large overlap of common methylated CpG sites. In conclusion, SI-NET primary and metastatic lesions show a highly varying degree of intratumoral heterogeneity. Driver events might not be detectable with exome analysis only, and further comprehensive studies including whole genome and epigenetic analyses are warranted.
format article
author Dirk Walter
Patrick N. Harter
Florian Battke
Ria Winkelmann
Markus Schneider
Katharina Holzer
Christine Koch
Jörg Bojunga
Stefan Zeuzem
Martin Leo Hansmann
Jan Peveling-Oberhag
Oliver Waidmann
author_facet Dirk Walter
Patrick N. Harter
Florian Battke
Ria Winkelmann
Markus Schneider
Katharina Holzer
Christine Koch
Jörg Bojunga
Stefan Zeuzem
Martin Leo Hansmann
Jan Peveling-Oberhag
Oliver Waidmann
author_sort Dirk Walter
title Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
title_short Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
title_full Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
title_fullStr Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
title_full_unstemmed Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
title_sort genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/b786fcb5b9e245fe84cd2828f5a059bc
work_keys_str_mv AT dirkwalter geneticheterogeneityofprimarylesionandmetastasisinsmallintestineneuroendocrinetumors
AT patricknharter geneticheterogeneityofprimarylesionandmetastasisinsmallintestineneuroendocrinetumors
AT florianbattke geneticheterogeneityofprimarylesionandmetastasisinsmallintestineneuroendocrinetumors
AT riawinkelmann geneticheterogeneityofprimarylesionandmetastasisinsmallintestineneuroendocrinetumors
AT markusschneider geneticheterogeneityofprimarylesionandmetastasisinsmallintestineneuroendocrinetumors
AT katharinaholzer geneticheterogeneityofprimarylesionandmetastasisinsmallintestineneuroendocrinetumors
AT christinekoch geneticheterogeneityofprimarylesionandmetastasisinsmallintestineneuroendocrinetumors
AT jorgbojunga geneticheterogeneityofprimarylesionandmetastasisinsmallintestineneuroendocrinetumors
AT stefanzeuzem geneticheterogeneityofprimarylesionandmetastasisinsmallintestineneuroendocrinetumors
AT martinleohansmann geneticheterogeneityofprimarylesionandmetastasisinsmallintestineneuroendocrinetumors
AT janpevelingoberhag geneticheterogeneityofprimarylesionandmetastasisinsmallintestineneuroendocrinetumors
AT oliverwaidmann geneticheterogeneityofprimarylesionandmetastasisinsmallintestineneuroendocrinetumors
_version_ 1718388083011878912